Activating the NLRP3 inflammasome using the amyloidogenic peptide IAPP

Methods in Molecular Biology

Volumn 1040, Issue , 2013, Pages 9-18

  Westwell Roper, Clara ^a   Dunne, Aisling ^b   Kim, Man Lyang ^c   Verchere, C Bruce ^a   Masters, Seth L ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Amyloid; IAPP; Inflammasome; Innate immunology; NLR

Indexed keywords

AMYLIN; AMYLOID; AMYLOID PROTEIN; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LACTATE DEHYDROGENASE; THIOFLAVINE;

ARTICLE; ATOMIC FORCE MICROSCOPY; BONE MARROW CELL; CELL CULTURE; CELL DEATH; CELL MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ISOLATION; WESTERN BLOTTING;

EID: 84880463747     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-523-1_2     Document Type: Article

References (16)

1. Tukel C, Wilson RP, Nishimori JH, Pezeshki M, Chromy BA, Baumler AJ (2009) Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2. Cell Host Microbe 6(1):45-53. doi: 10.1016/j. chom.2009.05.020, doi: S1931- 3128(09) 00213-3 [pii]
2. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Lacy-Hulbert A, El Khoury J, Golenbock DT, Moore KJ (2010) CD36 ligands promote sterile infl ammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11(2):155-161. doi: 10.1038/ni.1836, doi: Ni.1836 [pii]
3. Ather JL, Ckless K, Martin R, Foley KL, Suratt BT, Boyson JE, Fitzgerald KA, Flavell RA, Eisenbarth SC, Poynter ME (2011) Serum amyloid A activates the NLRP3 infl ammasome and promotes Th17 allergic asthma in mice. J Immunol 187(1):64-73. doi: 10.4049/jimmunol. 1100500, doi: Jimmunol.1100500 [pii]
4. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT (2008) The NALP3 infl ammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9(8):857-865. doi: 10.1038/ni.1636, doi: Ni.1636 [pii]
5. Niemi K, Teirila L, Lappalainen J, Rajamaki K, Baumann MH, Oorni K, Wolff H, Kovanen PT, Matikainen S, Eklund KK (2011) Serum amyloid A activates the NLRP3 infl ammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol 186(11):6119-6128. doi: 10.4049/jimmunol.1002843, doi: Jimmunol. 1002843 [pii]
6. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, Mullooly N, Mielke LA, Harris J, Coll RC, Mills KH, Mok KH, Newsholme P, Nunez G, Yodoi J, Kahn SE, Lavelle EC, O'Neill LA (2010) Activation of the NLRP3 infl ammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 11(10):897-904. doi: 10.1038/ni.1935, doi: Ni.1935 [pii]
7. Westwell-Roper C, Dai DL, Soukhatcheva G, Potter KJ, van Rooijen N, Ehses JA, Verchere CB (2011) IL-1 blockade attenuates islet amyloid polypeptide-induced proinfl ammatory cytokine release and pancreatic islet graft dysfunction. J Immunol. doi: 10.4049/jimmunol.1002854
8. Masters SL, O'Neill LA (2011) Diseaseassociated amyloid and misfolded protein aggregates activate the infl ammasome. Trends Mol Med 17(5):276-282. doi: 10.1016/j. molmed.2011.01.005
9. Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ Jr, Porte D Jr (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by betacells. Diabetes 39(5):634-638
10. Westermark P, Wernstedt C, Wilander E, Sletten K (1986) A novel peptide in the calcitonin gene related peptide family as an amyloid fi bril protein in the endocrine pancreas. Biochem Biophys Res Commun 140(3): 827-831
11. Westermark P (1972) Quantitative studies on amyloid in the islets of Langerhans. Ups J Med Sci 77(2):91-94
12. Bell ET (1959) Hyalinization of the islets of Langerhans in nondiabetic individuals. Am J Pathol 35(4):801-805
13. Zraika S, Hull RL, Verchere CB, Clark A, Potter KJ, Fraser PE, Raleigh DP, Kahn SE (2010) Toxic oligomers and islet beta cell death: Guilty by association or convicted by circumstantial evidence? Diabetologia 53(6):1046-1056. doi: 10.1007/s00125-010-1671-6
14. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (5618):486-489. doi: 10.1126/science.1079469300/ 5618/486 [pii]
15. Park K, Verchere CB (2001) Identifi cation of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation. J Biol Chem 276(20):16611-16616. doi: 10.1074/jbc.M008423200 M008423200 [pii]
16. Kudva YC, Mueske C, Butler PC, Eberhardt NL (1998) A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation. Biochem J 331(Pt 3): 809-813